US BROKER MOVES: URBN upgraded at Goldman Sachs; HUBS downgraded at Wells Fargo

UPGRADES Akari Therapeutics (AKTX) Upgraded to Buy at Maxim Group; PT USD 30 FRVO (FRVO) Upgraded to Buy at Jefferies; PT USD 34 (prev USD 41) Global Payments (GPN) Upgraded to Overweight at Morgan Stanley; PT USD 100 (prev USD 65) Harley-Davidson (HOG) Upgraded to Buy at Loop Capital Lumentum (LITE) Upgraded to Overweight at Barclays; PT USD 1,000 Nebius Group (NBIS) Upgraded to Buy at Freedom Capital; PT USD 200 (prev USD 159) Netflix (NFLX) Upgraded to Buy at Phillip Securities; PT USD 110 Urban Outfitters (URBN) Upgraded to Buy at Goldman Sachs; PT USD 93 (prev USD 76) U.S. Bancorp (USB) Upgraded to Outperform at Evercore ISI; PT USD 72 (prev USD 65) U.S. Bancorp (USB) Upgraded to Neutral at JPMorgan; PT USD 67.50 (prev USD 65) YETI Holdings (YETI) Upgraded to Buy at Goldman Sachs; PT USD 63 (prev USD 46) DOWNGRADES Allegro MicroSystems (ALGM) Downgraded to Equalweight at Barclays; PT USD 48 atai Life Sciences (ATAI) Downgraded to Hold at Berenberg atai Life Sciences (ATAI) Downgraded to Neutral at H.C. Wainwright; PT USD 7.50 Birkenstock (BIRK) Downgraded to Neutral at Seaport Global Securities Charles River Laboratories (CRL) Downgraded to Hold at CLSA; PT USD 219 Fidus Investment (FDUS) Downgraded to Market Perform at Keefe, Bruyette & Woods; PT USD 19.50 F.N.B. Corporation (FNB) Downgraded to Neutral at BofA Securities; PT USD 19 (prev USD 20) HubSpot (HUBS) Downgraded to Equal Weight at Wells Fargo; PT USD 225 (prev USD 300) Monster Beverage (MNST) Downgraded to Hold at Deutsche Bank; PT USD 98 (prev USD 94) Pengu (PENG) Downgraded to Underweight at Barclays; PT USD 40 Charles Schwab (SCHW) Downgraded to Market Perform at BMO Capital; PT USD 105 StoneX Group (SNEX) Downgraded to Hold at Jefferies; PT USD 112 (prev USD 123) Truist Financial (TFC) Downgraded to Underweight at JPMorgan; PT USD 53 (prev USD 53.50) INITIATIONS Adobe (ADBE) Initiated Outperform at CLSA; PT USD 300 AerCap Holdings (AER) Initiated Buy at Citi; PT USD 173 AN2 Therapeutics (ANTX) Initiated Buy at Guggenheim; PT USD 9 Apollo Global Management (APO) Initiated Buy at HSBC; PT USD 145 Apollo Global Management (APO) Initiated Market Perform at Keefe, Bruyette & Woods; PT USD 130 Ares Management (ARES) Initiated Market Perform at Keefe, Bruyette & Woods; PT USD 122 Broadway Financial (BWAY) Initiated Buy at BTIG; PT USD 18 Crane (CR) Initiated Outperform at BMO Capital; PT USD 253 Salesforce (CRM) Initiated Hold at CLSA; PT USD 165 DPC (DPC) Initiated Buy at Rothschild Redburn; PT USD 53.50 DPC (DPC) Initiated Buy at Jefferies; PT USD 56 DPC (DPC) Initiated Equalweight at Morgan Stanley; PT USD 47 DPC (DPC) Initiated Outperform at RBC Capital; PT USD 53 Microsoft (MSFT) Initiated Outperform at CLSA; PT USD 535 NN (NNBR) Initiated Buy at Craig-Hallum; PT USD 7 ServiceNow (NOW) Initiated Underperform at CLSA; PT USD 72 Enpro (NPO) Initiated Overweight at JPMorgan; PT USD 420 Oracle (ORCL) Initiated Hold at CLSA; PT USD 145 Ralliant (RAL) Initiated Market Perform at BMO Capital; PT USD 78 ReNetX Bio (RNTX) Initiated Buy at Maxim Group; PT USD 4 Regal Rexnord (RRX) Initiated Buy at Deutsche Bank; PT USD 286 Shell (SHEL) Initiated Neutral at Mizuho; PT USD 98 Soluna Holdings (SLNH) Initiated Buy at H.C. Wainwright; PT USD 4 SOPHiA GENETICS (SOPH) Initiated Buy at H.C. Wainwright; PT USD 12 Sportradar (SRAD) Initiated Buy at Freedom Capital; PT USD 20 Neuronetics (STIM) Initiated Buy at BTIG; PT USD 5 Starkey (STTK) Initiated Outperform at Leerink; PT USD 16 TotalEnergies (TTE) Initiated Outperform at Mizuho; PT USD 103 TTRX (TTRX) Initiated Buy at Ladenburg Thalmann; PT USD 26 Vangent (VGNT) Initiated Buy at Goldman Sachs; PT USD 48 Workday (WDAY) Initiated Underperform at CLSA; PT USD 92